Effect of Ambrisentan Treatment on Exercise-Induced Pulmonary Hypertension in Systemic Sclerosis: A Prospective Single-Center, Open-Label Pilot Study

Objective Exercise-induced pulmonary hypertension (ePH) may represent an early, clinically relevant phase in the spectrum of pulmonary vascular disease. The purpose of this pilot study was to describe the changes in hemodynamics and exercise capacity in patients with systemic sclerosis (SSc) spectru...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Arthritis & rheumatology (Hoboken, N.J.) N.J.), 2012-12, Vol.64 (12), p.4072-4077
Hauptverfasser:	SAGGAR, Rajeev, KHANNA, D, SHAPIRO, S, FURST, D. E, MARANIAN, P, CLEMENTS, P, ABTIN, F, DUA, Shiv, BELPERIO, J, SAGGAR, Rajan
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological and medical sciences Diseases of the osteoarticular system Medical sciences Pneumology Pulmonary hypertension. Acute cor pulmonale. Pulmonary embolism. Pulmonary vascular diseases Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!